Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 34 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

26%

9 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

8 recruiting

Enrollment Performance

Analytics

Phase 2
9(34.6%)
Phase 3
8(30.8%)
N/A
7(26.9%)
Phase 4
1(3.8%)
Phase 1
1(3.8%)
26Total
Phase 2(9)
Phase 3(8)
N/A(7)
Phase 4(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (34)

Showing 20 of 34 trials
NCT05384444Not ApplicableActive Not Recruiting

Effect of FMD on Colorectal Cancer Patients

Role: collaborator

NCT07441369Phase 2Enrolling By Invitation

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

Role: collaborator

NCT07312526Completed

Shanghai Clinical Cohort - Esophageal Cancer

Role: collaborator

NCT07490119Phase 2Not Yet Recruiting

Becotatug Vedotin Combined With Cetuximab in the Later-line Treatment of Metastatic RAS Wild-type Colorectal Cancer

Role: collaborator

NCT07414758Phase 3Recruiting

Golidocitinib Versus Placebo as Maintenance Therapy in PTCL Patients With Response (CR/PR) After First-Line Chemotherapy

Role: collaborator

NCT07402525Not ApplicableRecruiting

Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial

Role: collaborator

NCT03013010Phase 3Completed

PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy

Role: lead

NCT06686979Recruiting

PDO Based Drug Sensitive Test in R/M SGC

Role: collaborator

NCT06686342Recruiting

PDO Based Drug Sensitive Test in R/M HNSCC

Role: collaborator

NCT06679244Not ApplicableRecruiting

Application of a New Surgical Technique in Proximal Gastrectomy: a Prospective, Multicenter Randomized Controlled Study

Role: collaborator

NCT06901817Phase 2Recruiting

A Study of the Safety and Efficacy of Pemetrexed Combined with Nivolumab Via Intraventricular Injection for the Treatment of Refractory Non-squamous Non-small Cell Lung Cancer with Leptomeningeal Metastases

Role: lead

NCT06754293Not ApplicableActive Not Recruiting

Evaluating the Efficacy of Structured Exercise Interventions in Alleviating Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors: a Pilot Study Protocol

Role: collaborator

NCT06717009Not ApplicableNot Yet Recruiting

A Study of 3D Visualization Techniques to Improve the Quality and Safety of Robot-assisted Nephron Sparing Surgery for Complex Renal Tumors.

Role: collaborator

NCT06709144Phase 3Active Not Recruiting

Borderline of CME/D3 Dissection for Local Advanced Right-sided Colon Cancer

Role: collaborator

NCT05844813Phase 4Enrolling By Invitation

Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma

Role: collaborator

NCT05800223Phase 3Recruiting

Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer

Role: lead

NCT04519983Phase 2Unknown

Efficacy of SRT as Salvage Therapy in Patients With Brain Oligo-progression of EGFR-mutant Non-small Cell Lung Cancer After Failure of the Third-generation EGFR-TKIs

Role: lead

NCT05407649Phase 2Unknown

Abscopal Effect of Radiotherapy in Combination With rhGM-CSF for Advanced Thymic Epithelial Tumours

Role: lead

NCT04850027Unknown

MRI-guided Lateral Lymph Node Dissection in Rectal Cancer

Role: collaborator

NCT04764240Completed

Precisely Estimation of the Prognostic Value of Lymph Node in ESCC

Role: lead